DELETE – Micardis at a Glance
Telmisartan is an angiotensin II receptor antagonist that selectively blocks the AT1 receptor subtype, making it a valuable research tool for studying cardiovascular and metabolic pathways. As the longest-acting compound in its class, this Boehringer Ingelheim formulation provides researchers with a stable platform for investigating renin-angiotensin system modulation. Laboratories worldwide utilise telmisartan to examine its effects on vascular tone, aldosterone secretion, and cellular signalling cascades. The compound’s unique pharmacological profile, including partial PPARδ agonist activity, offers researchers opportunities to study metabolic regulation beyond traditional cardiovascular applications. Scientists at Stroid UK Shop and research institutions globally continue to explore telmisartan’s molecular mechanisms in preclinical models.
Laboratory Applications
Research applications for telmisartan span multiple physiological systems, with primary focus on cardiovascular biology and metabolic regulation. Investigators examine its selective AT1 receptor antagonism in hypertension models, while exploring secondary metabolic effects through PPARδ pathway modulation. Cell culture studies investigate telmisartan’s effects on endothelial function, smooth muscle cell proliferation, and inflammatory marker expression. Advanced research protocols evaluate the compound’s influence on glucose metabolism, lipid oxidation, and insulin sensitivity pathways. For researchers expanding their compound libraries, our telmisartan collection provides various formulations. Comparative studies often incorporate SARMs and peptides to examine receptor selectivity and tissue-specific responses in controlled laboratory environments.
Technical Specifications
| Active Compound | Telmisartan |
|---|---|
| Manufacturer | Boehringer Ingelheim |
| Strength | 80mg per tablet |
| CAS Number | 144701-48-4 |
| Molecular Formula | C₃₃H₃₀N₄O₂ |
| Molecular Weight | 514.62 g/mol |
| Storage Requirements | Room temperature, dry conditions |
Research Compliance Notice
This telmisartan 80mg product is manufactured by Boehringer Ingelheim exclusively for in-vitro laboratory research applications. The compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure proper handling protocols, adequate ventilation, and appropriate disposal procedures when working with this material. All studies should be conducted by qualified personnel familiar with pharmaceutical research safety standards and institutional review board guidelines.
